Spinning Plates, Not Dropping Them | NPA Saga Update

We are running multiple strands in parallel and none of them are being dropped. We do rotate which plate gets the most attention at a given moment. That is on purpose. It keeps the story accurate, the record clean, and the next step harder to wiggle out of.

The misrepresentation article tied to the National Pharmacy Association (NPA) saga was slated for Sunday night just gone. After their latest message landed, with the usual mixture of posturing and a weak attempt at intimidation, I chose to publish a focused response to that tactic first. Combining the two would have blurred the point and invited yet another round of performative complaints in my inbox. The dedicated misrepresentation piece will still land, on its own terms, with source material and timestamps.

Clarity over noise. When organisations escalate with heat instead of facts, we strip it back to the record. We quote, we show logs, we sequence the evidence so that readers can follow without guesswork.

Nobody is under the radar

If anyone watching this thinks they have slipped past the beam, understand this clearly. You have not. The spotlight rotates. Your time will come.

Where to start if you are catching up

• They Read, They Probed, We Logged Everything — on net access plus cloud probes, with bait domain referrers.
• The Right Withheld: How Silence Became NPA’s Only Defence — email trails, deadlines, and analytics corroboration.
• IPS Pharma, represented by NPA — structured background, patient safety breach, and governance link.
• IPS Pharma Privacy Breach — findings and fixes, evidence preserved.
• Progress Report: NPA fixed links, Puro moved fast, IPS still stuck on 2018 — credit where due, and where it is not.

What happens next

The intimidation response publishes first. It covers exactly what was said, why it is not persuasive, and the standards that actually apply. The misrepresentation article follows, focused only on claims, evidence, and corrections. That order is deliberate. It prevents cross talk, keeps each thread tight, and avoids handing anyone an easy excuse to complain about process instead of substance.

Publication here is paced, not paused. If you are named, you will be quoted fairly and linked in full. If you fix something, that will be recorded too. If you double down, that will be clear on the page next to the timestamps.